Skip to main content
Molecular Biology of the Cell logoLink to Molecular Biology of the Cell
. 2018 Aug 15;29(17):2037–2044. doi: 10.1091/mbc.E18-02-0096

Correlation of CRM1-NES affinity with nuclear export activity

Szu-Chin Fu 1, Ho Yee Joyce Fung 1, Tolga Cağatay 1, Jordan Baumhardt 1, Yuh Min Chook 1,*
Editor: Karsten Weis2
PMCID: PMC6232958  PMID: 29927350

Abstract

CRM1 (Exportin1/XPO1) exports hundreds of broadly functioning protein cargoes out of the cell nucleus by binding to their classical nuclear export signals (NESs). The 8- to 15-amino-acid-long NESs contain four to five hydrophobic residues and are highly diverse in both sequence and CRM1-bound structure. Here we examine the relationship between nuclear export activities of 24 different NES peptides in cells and their CRM1-NES affinities. We found that binding affinity and nuclear export activity are linearly correlated for NESs with dissociation constants (Kds) between tens of nanomolar to tens of micromolar. NESs with Kds outside this range have significantly reduced nuclear export activities. These include two unusually tight-binding peptides, one from the nonstructural protein 2 of murine minute virus (MVM NS2) and the other a mutant of the protein kinase A inhibitor (PKI) NES. The crystal structure of CRM1-bound MVM NS2NES suggests that extraordinarily tight CRM1 binding arises from intramolecular contacts within the NES that likely stabilizes the CRM1-bound conformation in free peptides. This mechanistic understanding led to the design of two novel peptide inhibitors that bind CRM1 with picomolar affinity.

INTRODUCTION

Nuclear-cytoplasmic transport of macromolecules is largely mediated by karyopherin-β family nuclear transport receptors (Kaps; importins and exportins). Importins bind their cargoes in the cytoplasm and release them in the nucleus whereas exportins mediate the reverse process. The chromosome region maintenance 1 (CRM1) protein (also known as exportin-1 or XPO1) binds 8- to 15-residues-long nuclear export signals (NESs) in hundreds of different protein cargoes (Fornerod et al., 1997; Fukuda et al., 1997; Ossareh-Nazari et al., 1997; Stade et al., 1997; Thakar et al., 2013). The repertoire of the protein cargoes of CRM1 continues to grow; ∼250 experimentally identified protein cargoes are recorded in NES databases ValidNESs and NESdb (Fu et al., 2012; Xu et al., 2012, 2015), and over 1000 putative CRM1 cargoes were identified in a recent proteomics study (Kırlı et al., 2015). Accordingly, the diversity of NES sequences has also grown with ever-expanding NES patterns that result in many false positives when used in NES prediction. Further complexity is observed as recent structural analysis of 13 different CRM1-NES complexes revealed a large range of NES backbone conformations (Fung et al., 2017). Nevertheless, the study of NES recognition by CRM1 is important as CRM1-NES interactions are the targets of small molecule inhibitors such as Selinexor/KPT-330, Eltanexor/KPT-8602, Verdinexor/KPT-335, KPT-350 (Karyopharm), and SL801 (Stemline), which are being tested in clinical trials for a variety of cancers and inflammatory diseases or as an antiviral agent.

In addition to CRM1, the importin α/β (Impα/β) system also recognizes hundreds to thousands of broadly functioning cargoes, in this case proteins that contain the classical nuclear localization signal (cNLS). Extensive structural, biochemical, and cell biological studies of cNLS recognition by Impα preceded analogous CRM1-NES studies (Conti et al., 1998; Kobe, 1999; Marfori et al., 2011). More than 80 crystal structures of Impα-cNLS complexes are available, showing how various poly-basic monopartite and bipartite cNLS peptides interact with two binding sites on several Impα isoforms. Nuclear import activities of different cNLS peptides in cells and their affinities for Impα were measured and compared (Fanara et al., 2000; Hodel et al., 2001, 2006). These studies roughly divided cNLSs into three groups: 1) active NLSs with KDs from 1 nM to hundreds of nanomolar where nuclear import appears to correlate with Impα-cNLS affinity, 2) inactive NLSs with dissociation constants (Kds) in the micromolar range, and 3) NLSs that bind with Kds < 1 nM, which exhibited a saturated maximum nuclear import activity (Hodel et al., 2006). More recent studies have shown two nonclassical nuclear localization signal (ncNLS) that bind exclusively to the minor NLS-binding site of importin-α with micromolar affinities are also active NLSs in cells. These studies suggest that binding affinities between active NLSs and Impα can vary over three orders of magnitude with Kds ranging from nanomolar to micromolar (Lott et al., 2011; Nakada et al., 2015; Wu et al., 2017). However, no equivalent studies of the dynamic range of nuclear export activity versus CRM1-NES affinity have been reported.

Here we measured the cytoplasmic-to-nuclear ratios, in live cells, of a fluorescent reporter that is fused to 24 different NES sequences to report on nuclear export activities of the NESs. Comparison with their affinities for CRM1 revealed a strong linear correlation of nuclear export activity and CRM1-NES affinity for NESs that bind CRM1 with Kds that range from tens of nanomolar to tens of micromolar. Peptides that bind CRM1 with Kds > 150 µM do not direct nuclear export in cells, suggesting an upper limit in CRM1-NES Kd values for optimal nuclear export. When NESs bind CRM1 with Kds < 5 nM, their nuclear export activities are also significantly reduced. These supertight NESs also inhibit nuclear export of average NESs. Structure of a supertight peptide bound to CRM1 showed intramolecular contacts that were not observed in other CRM1-NES structures. The use of this unusual NES structural element led to the design of two peptide inhibitors that bind CRM1 with picomolar affinity.

RESULTS AND DISCUSSION

Measuring NES activity in live cells

We selected 24 different NES peptides to measure nuclear export activities in cells. The NESs were selected to sample a broad range of affinity for CRM1 based on qualitative estimates from previous pull-down binding assays (Xu et al., 2012, 2015). The NES from protein kinase A inhibitor (PKINES; 34NSNELALKLAGLDINK49) was used as positive control. Two known inactive PKINES mutants, PKINES(I47A) and PKINES(L42A/L45A), served as negative controls (Wen et al., 1995). Plasmids encoding enhanced yellow fluorescent protein (EYFP2)-SV40NLS-NES fusion proteins were transfected into HeLa cells and the nuclear-cytoplasmic distribution of the fluorescent reporter proteins were recorded by live cell confocal microscopy. The ratio of mean fluorescence intensity of EYFP2-SV40NLS-NES in the cytoplasm to mean fluorescence intensity in the nucleus (RC/N) is used as a measure of nuclear export activity. CRM1-mediated nuclear export was demonstrated by nuclear accumulation of EYFP2-SV40NLS-NES following treatment with 5 nM leptomycin B (LMB) for 16–18 h. Since LMB inhibits CRM1, the RC/N with LMB treatment can account for passive export of reporter proteins by diffusion. Therefore, we normalized observed RC/N of each NES peptide with its corresponding RC/N value on LMB treatment. The quantitative workflow of the imaging study is described in Figure 1A. Representative images of inactive, moderate and strong NESs are shown in Figure 1B (all other NESs are shown in Supplemental Figure S1A).

FIGURE 1:

FIGURE 1:

Correlation of NES export activity with binding affinity to CRM1. (A) Schematic of the workflow to quantify the ratio of cytoplasmic to nuclear mean fluorescence intensity (RC/N). RC/N values are used as a measurement of NES activity in living HeLa cells. The loop in the workflow indicates that this process is repeated for at least 30 representative cells collected from at least three independent experiments (listed in Table 2) for statistical analysis. (B) Leptomycin B (LMB) sensitive nuclear export activity of EYFP2-SV40NLS-NES fusion proteins in HeLa cells. YFP (pseudocolored in yellow) and Hoechst (pseudocolored in blue) images were captured using spinning disk confocal microscope (40×). From left to right, PKINES, HIV RevNES, and CDC7NES. Nuclear accumulation after treatment with 5 nM leptomycin B (+LMB) for 16–18 h demonstrates CRM1-dependent export. Representative images of all other NESs are shown in Supplemental Figure S1A. (C) Correlation of in vitro affinity and in vivo nuclear export activity. In vitro binding affinities of 24 NESs (includes two negative controls PKINES(I47A) and PKINES(L42A/L45A)) are plotted as a function of their nuclear export activities. Error bars represent 95% confidence intervals. Half of the vertical error bars for the binding affinities of PKINES(L42A/L45A), Super PKINES, and MVM NS2NES are missing because the upper or lower limits are undetermined. The Pearson’s r value of the 24 NESs is –0.65 (p = 0.0006) and is –0.87 (p = 1.48 × 10-7) when Super PKINES and MVM NS2NES are not included.

To examine the impact of variation in reporter protein expression on nuclear export activity among different cells, we analyzed the correlation between RC/N and the expression level of EYFP2-SV40NLS-NES in the cell. As shown in Supplemental Figure S2A, RC/N values are plotted for individual HeLa cells as a function of the mean fluorescence intensity of the whole cell. Analysis of four different NESs (EYFP2-SV40NLS-StradαNES, EYFP2-SV40NLS-HIV RevNES, EYFP2-SV40NLS-MEK1NES, and EYFP2-SV40NLS-MVM NS2NES) showed no correlation between the RC/N and the expression level of reporter proteins in the cell, suggesting that variation in expression level (at least across the range examined here) does not affect CRM1-mediated export of the reporter proteins.

Measuring CRM1-NES affinities

CRM1-NES binding affinities (dissociation constants or Kds) were measured using a previously described differential bleaching assay, with purified CRM1 and NES proteins in the presence of excess RanGTP (Fung et al., 2015). MBP-NES fusion proteins were used as the MBP tag does not affect interactions with CRM1 (Fung et al., 2015). Kd values are reported with 95% confidence intervals obtained using error-surface projection method. The Kd values of the 24 different NESs binding to CRM1 range from low nanomolar to a hundred micromolar (Table 1; differential bleaching data shown in Supplemental Figure S3, A and B). Negative controls, PKINES(I47A) and PKINES(L42A/L45A) mutants (Wen et al., 1995), have Kd values >150 μM, suggesting extremely weak binding. Analysis of simulated differential bleaching data in PALMIST (Scheuermann et al., 2016) indicated that the high-affinity detection limit of our experiments is ∼1 nM Kd (Supplemental Figure S3C; see details under Materials and Methods). Therefore, Kd values of several high-affinity NESs (Super PKINES and MVM NS2NES; Table 1) are beyond the limit of accurate determination. Kds with undefined confidence intervals are reported as such and are used for rough comparisons.

TABLE 1:

In vitro CRM1 binding affinity and in vivo activity of NESs.

RC/N 95% confidence interval Kd 95% confidence interval
NES Mean RC/N Low High Kd (nM) Low High
PKI 1.37 1.33 1.41 34b 25 46
CPEB4 1.20 1.13 1.27 800b 500 1200
MEK1a 1.17 1.11 1.23 70 40 130
ADAR1a 0.85 0.75 0.96 69 49 96
hRio2 0.82 0.72 0.92 2800b 1700 4700
FMRP 0.81 0.76 0.86 2000 1200 3400
Super PKIa 0.80 0.64 0.96 4 Uc 12
X11L2 0.79 0.71 0.87 1500 900 2300
NPMmutA 0.72 0.61 0.83 790 640 980
HIV Reva 0.70 0.62 0.77 1180 990 1400
Pax 0.60 0.49 0.70 700 400 1000
mDia2 0.59 0.52 0.66 1600 1000 2700
CPEB4-R 0.59 0.50 0.67 710b 560 880
p73a 0.59 0.53 0.65 2000 1700 2400
HDAC5 0.54 0.48 0.60 1600 1100 2400
SMAD4 0.44 0.37 0.51 4600 3600 5900
MVM NS2a 0.38 0.30 0.45 2 Uc 9
hRio2-R 0.36 0.30 0.43 2600b 2000 3300
HPV E7a 0.29 0.24 0.33 34,000 22,000 53,000
CDC7 0.21 0.16 0.26 20,000 15,000 27,000
Stradαa 0.19 0.13 0.26 10,300 8000 13,000
SNUPN 0.16 0.12 0.20 12,500b 10,000 15,000
PKI (I47A) 0.03 0.02 0.04 150,000 90,000 310,000
PKI (L42A/L45A)a 0.01 0.00 0.02 900,000 300,000 Uc

aBinding affinities measured in this study. Others were measured in our previous studies and reanalyzed to obtain 95% confidence interval.

bKd reported here are slightly different from before as all data are now fitted using averages of triplicate experiments without weighted fitting. The absolute numbers are only slightly different from previously reported and differences are insignificant.

cU, cannot be defined.

Comparing NES activities in cells and CRM1-NES affinities

We plotted CRM1-NES affinity (log10Kd, where Kd is in nanomolar) as a function of its RC/N or nuclear export activity. Both parameters are presented with error bars showing their respective 95% confidence limits (Figure 1C). The plot revealed a strong negative correlation between log10Kd and RC/N as indicated by Pearson’s r = –0.65 (p = 0.0006). Active NESs have an impressively wide range of affinities for CRM1 that span four orders of magnitude, from Kds of single-digit nanomolar to tens of micromolar. The NES from the murine minute virus nonstructural protein 2 (MVM NS2NES) has the highest affinity for CRM1 (Kd = 2 nM). At the other end, there are four active NESs with Kds of tens of micromolar: StradαNES (Kd = 10 µM), SNUPNNES (K d = 13 µM), CDC7NES (Kd = 20 µM), and HPV E7NES (Kd = 34 µM). The measured Kds of two known inactive PKINES mutants are 150 and 900 µM, respectively. Interestingly, two unusually tight-binding NES peptides with Kds < 5 nM also have low nuclear export activity in cells. One of the supertight NES is MVM NS2NES, while the other is the N35L mutant of PKINES, termed the Super PKINES, which was previously designed to increase CRM1 affinity for crystallographic study (Güttler et al., 2010). When these two unusually tight-binding NESs were excluded from the analysis, the correlation coefficient between CRM1 affinity and nuclear export activity increased to a Pearson’s r = –0.87 (p = 1.48 × 10-7). We note that interactions between CRM1 and full-length cargo proteins may be more complicated and require further investigations that include physiological concentrations of CRM1, cargoes, Ran, and other cargo proteins. Caution is advised when translating the Kds reported in this study into CRM1-full-length cargo affinities.

It is generally thought that karyopherin-NLS/NES interactions should occur within a range of affinity suitable for both binding in one cell compartment and release in the other compartment. The two inactive PKINES mutants PKINES(I47A) and PKINES(L42A/L45A) (Wen et al., 1995) have RC/N values of 0.03 and 0.01 that are consistent with their lack of activity (Table 1). The measured Kd of PKINES(I47A) for CRM1 is 150 [90, 310] μM (values in bracket represent 95% confidence interval). The next weakest CRM1 binder is the HPV E7NES (Kd = 34 [22, 53] μM), which has a significantly higher RC/N value of 0.29. On the basis of these data points, we suggest that the lower limit of binding affinity for active nuclear export likely lie between 34 and 150 µM.

CRM1-NES interactions must also occur at affinities suitable for cargo/NES release in the cytoplasm. Therefore, there is likely an upper limit of CRM1-NES affinity for optimal nuclear export. An NES or cargo that binds CRM1 tighter than this limit will likely remain bound to CRM1 after RanGTP is hydrolyzed to RanGDP in the cytoplasm and potentially be taken back into the nucleus. Two NESs that bind CRM1 with Kds < 5 nM, Super PKINES (Kd = 4 [U, 12] nM; U cannot be defined) and MVM NS2NES (Kd = 2 [U, 9] nM), exhibit 42–72% lower nuclear export activity than the lower affinity PKINES (Kd = 34 [25, 46] nM). These results suggest that the upper limit of CRM1-NES affinity for optimal nuclear export activity lies between 4 and 34 nM. Previous studies (Engelsma et al., 2008; Güttler et al., 2010) and pull-down binding data shown in Supplemental Figure S3D show that these two unusually tight-binding NESs can bind CRM1 in the absence of RanGTP, suggesting that their interactions with CRM1 in cells may be independent of Ran.

The supertight NESs can inhibit nuclear export

A protein or peptide that binds CRM1 too tightly may outcompete bona fide cargoes. Engineered peptides like the Bimax or M9M peptides, which bind Impα or Kapβ2, respectively, with picomolar affinities, are inhibitors of the karyopherins (Cansizoglu et al., 2007; Kosugi et al., 2008). We wondered whether the unusually tight Super PKINES and MVM NS2NES can function as CRM1 inhibitors. We cotransfected HeLa cells with EYFP2-SV40NLS-PKINES and either RFP-MVM NS2NES or RFP-Super PKINES. Figure 2A shows that transfection with either RFP-MVM NS2NES or RFP-Super PKINES decreased nuclear export of PKINES substantially (by 74–87%). The inhibitory effect here is similar to but not as strong as that of leptomycin B (LMB), a very potent small molecule covalent inhibitor of CRM1, which decreased nuclear export of PKINES by 92%. Interestingly, cotransfection of a strong NES like RFP-PKINES (Kd = 34 nM) with EYFP2-SV40NLS-X11L2NES did not affect nuclear export of weaker-binding X11L2NES (Kd = 1500 nM; Figure 2B). These results suggest that only the extraordinarily tight-binding NESs, with Kds below the active NES limit, can indeed inhibit nuclear export of other NESs. Representative images of cells cotransfected with reporter proteins (EYFP2-SV40NLS-PKINES) and RFP-tagged competitive peptides, or treated with LMB, are shown in Figure 2C. In addition, the mean RFP and YFP intensities of the whole cell were measured and used to calculate the expression ratio of competitive peptide to reporter in individual cells (Supplemental Figure S1C).

FIGURE 2:

FIGURE 2:

Inhibitory effect of extraordinary tight-binding NESs. (A) EYFP2-SV40NLS-PKINES is cotransfected with RFP, RFP-MVM NS2NES, RFP-Super PKINES, RFP-PKINES, or RFP- X11L2NES and compared with cells expressing EYFP2-SV40NLS-PKINES that are treated with small molecule inhibitor LMB. (B) EYFP2-SV40NLS-X11L2NES is cotransfected with RFP, RFP-MVM NS2NES, RFP-Super PKINES, RFP-PKINES, or RFP-X11L2NES and compared with cells expressing EYFP2-SV40NLS-PKINES that are treated with small molecule inhibitor LMB. The numbers of examined cells from at least three independent experiments are indicated in parentheses in A and B. Error bars represent SD. The p values were calculated in comparison to control (reporter only) using Mann–Whitney tests. Note that observed RC/N values are presented without normalization to compare with RC/N on LMB treatment (+LMB). (C) Representative images of cells transfected with EYFP2-SV40NLS-PKINES (reporter) and RFP-tagged NESs (competitive peptides). YFP (pseudocolored in yellow), Hoechst (pseudocolored in blue), and RFP (pseudocolored in red) images were captured using spinning disk confocal microscope (40×). The expression levels of reporter proteins and competitive peptides and are summarized in Supplemental Figure S1C.

Crystal structure of MVM NS2NES bound to CRM1

The structure of Super PKINES (fused to the Snurportin-1 protein) bound to CRM1 showed the leucine in the N35L mutation site binding in the P0 pocket of the CRM1 NES-binding groove. This additional contact increases the number of anchoring hydrophobic residues from four in wild-type PKINES to five in the supertight mutant (Güttler et al., 2010). It is unclear from the sequence of MVM NS2NES (77STVDEMTKKFGTLTIHD93) why it binds CRM1 so tightly. Using the engineered CRM1-Ran-RanBP1-NES quaternary complex (Fung et al., 2015), we solved the 2.0-Å resolution crystal structure of MVM NS2NES bound to CRM1 (Figure 3A, crystallographic statistics in Supplemental Table S1, and electron densities for the NES peptide in Figure 3B). MVM NS2NES binds CRM1 with the common NES conformation of an N-terminal α-helix followed by a C-terminal strand. Five hydrophobic side chains of MVM NS2NES (Val79, Met82, Phe86, Leu89, and Leu91) occupy the five hydrophobic pockets in the CRM1 groove (Figure 3A, left panel). The structures of CRM1-bound Super PKINES and MVM NS2NES are highly similar (Cα root mean square deviation [r.m.s.d.] of 0.7 Å for 13 NES residues) and the NES-bound CRM1 grooves are virtually identical (Cα r.m.s.d. of 0.5 Å for 85 CRM1 groove residues). However, unique to CRM1-bound MVM NS2NES are two intramolecular polar contacts involving the C-terminal strand of MVM NS2NES (Figure 3A, right panel). Thr90 of MVM NS2NES makes hydrogen bonds with both the side chain and main chain amides of MVM NS2NES His92. These intrapeptide contacts likely stabilize the configuration of the C-terminal strand, perhaps preorganizing the structural element, for the unusual high-affinity binding to CRM1. Such intramolecular NES contacts have not been observed in any other CRM1-NES structures (Dong et al., 2009; Güttler et al., 2010; Fung et al., 2015, 2017).

FIGURE 3:

FIGURE 3:

Crystal structure of MVM NS2NES bound to CRM1 and design of picomolar affinity peptide inhibitors. (A) Left, MVM NS2NES (pink cartoon) binds CRM1 (gray surface) like a typical class 1a NESs, with an N-terminal helix and C-terminal strand. Right, Details of CRM1-NES interaction. Black dotted lines show polar contacts within the NES (pink cartoon) and between the NES and CRM1 (gray cartoon). (B) Final refined model of the NES (pink sticks) overlaid onto electron density meshes of 2mFo-DFc map contoured at 1.0σ and kick OMIT map (calculated by omitting the NES peptide) contoured at 3.0σ. (C) Sequences of wild-type NES sequences and their chimera with MVM NS2NES. Φ side chains in the NESs that bind hydrophobic pockets in the CRM1 groove are numbered and underlined. (D) Differential bleaching data of MBP-Super PKI-NS2NES and MBP-CDC7-NS2NES binding to CRM1. Direct titrations of FITC-PKINES to CRM1 and RanGTP are shown in black and competition titrations of MBP-NESs to FITC-PKINES, CRM1, and RanGTP are shown in color. Dissociation constants (Kd) are obtained from triplicate titrations and 95% confidence intervals are reported in brackets. U = cannot be defined.

Structure-based design of novel peptide inhibitors

To investigate the importance of the unusual intrapeptide contacts seen in CRM1-bound MVM NS2NES, we generated chimeric NES peptides where 89LTIHD93 of MVM NS2NES is fused to N-terminal helical portions of other NESs. We asked whether the 89LTIHD9 strand of MVM NS2NES, which contains the intramolecular contacts, could increase affinities of the chimeric NES peptides for CRM1. Fusion of 89LTIHD93 to the very tight-binding Super PKINES (Kd = 4 [U, 12] nM) resulted in chimeric mutant Super PKI-NS2NES (NLELALKAGLTIHD). Fusion to the weak-binding CDC7NES (Kd = 20 [15, 27] μM) gave chimera CDC7-NS2NES (QDLRKLCERLRGLTIHD) (Figure 3C). Differential bleaching measurement of MBP-Super PKI-NS2NES and MBP-CDC7-NS2NES binding to CRM1 gave Kd values of 7 [U,U] and 27 [U,U] pM, respectively. Both chimeric peptides have picomolar affinity beyond the limit of accurate determination with our method (Figure 3D). These results indicate that the C-terminal 89LTIHD93 residues of MVM NS2NES contribute significant binding energy for interactions with CRM1. The transfer of this MVM NS2NES segment can increase affinities of other NESs by as much as 4 orders of magnitude (Kd of CDC7-NS2NES ≪ 1 nM vs. Kd of CDC7NES = 20 μM). More importantly, the intramolecular contacts within 89LTIHD93 appear to contribute significantly to the increased affinity of the NESs. The differences between Super PKINES and Super PKI-NS2NES occur only in non-Φ residues; LDINK in Super PKINES vs. LTIHD in Super PKI-NS2NES (Φ residues in bold; Figure 3C). The three-residue change increased binding affinity from 4 nM to ≪1 nM. We show that the picomolar affinity Super PKI-NS2NES peptide is an effective CRM1 inhibitor in the cell (Supplemental Figure S1B), much like the engineered M9M peptide that specifically and potently inhibits Kapβ2 (Cansizoglu et al., 2007). Finally, we also examined the effect of overexpression of Super PKI-NS2NES on cytotoxicity to T-REx-293 cells using a tetracycline-induced expression system (Supplemental Figure S2B). Although overexpression of Super PKI-NS2NES is cytotoxic, it does not alter the subcellular localization of endogenous CRM1 (Supplemental Figure S2C).

Conclusion

There is a strong correlation between CRM1-NES affinity and nuclear export activity for NESs that bind CRM1 with Kds in the tens of nanomolar to tens of micromolar range. The wide affinity range for active NESs draws parallels with the Impα/NLS system, which was reported to have a range of affinity that spans at least two orders of magnitude (Hodel et al., 2006). Taken together, these wide ranges of binding affinities may correlate with CRM1 and Impα/β’s ability to transport hundreds of cargo proteins with diverse signal sequences. However, once beyond Kd of 150 µM, NESs no longer seem to be exported into the cytoplasm. Conversely, when NESs have Kds tighter than 5 nM, their nuclear export activities are significantly reduced. These extraordinarily tight-binding NES sequences are able to inhibit nuclear export of other NESs. On the basis of these findings, we designed two peptide inhibitors that bind CRM1 with subnanomolar affinity.

MATERIALS AND METHODS

Cloning

NES sequences, along with three to five immediately adjacent residues on either ends, were cloned into different vectors used in this study (Table 2). To measure the in vivo activity and the in vitro binding affinity for CRM1, the same NES sequences were cloned into BamHI and XhoI sites of pEYFP2-SV40NLS and pMal-TEV vectors, respectively. For the use of peptide inhibition assay, MSM NS2NES, Super PKINES, and Super PKI-NS2NES were cloned into XhoI and HindIII sites of the pmKate2-C vector. All constructs were cloned using procedures as previously described (Xu et al., 2015) and verified by sequencing.

TABLE 2:

NES sequences, number of cells, and experiments in NES activity assay.

NES Sequence No. of cells No. of experiments
PKI 34NSNELALKLAGLDINK49 108 12
CPEB4 379RTFDMHSLESSLIDIMR395 30 3
MEK1 28TNLEALQKKLEELELDE44 44 3
ADAR1 121RGVDCLSSHFQELSIYQ137 33 4
hRio2 389RSFEMTEFNQALEEIKG405 32 3
FMRP 424LKEVDQLRLERLQID438 37 3
Super PKI 34NLNELALKLAGLDINK49 32 3
X11L2 55SSLQELVQQFEALPGDLV72 59 3
NPMmutA 278MTDQEAIQDLCLAVEEVSLRK298 32 3
HIV Rev 73LQLPPLERLTLDC85 42 4
Pax 264RELDELMASLSDFKFMA280 37 3
mDia2 1157SVPEVEALLARLRAL1171 36 4
CPEB4-R 395RMIDILSSELSHMDFTR379 33 3
p73 364NFEILMKLKESLELMELVP382 48 4
HDAC5 1081EAETVSAMALLSVG1095 35 3
SMAD4 134ERVVSPGIDLSGLTLQ149 32 3
MVM NS2 77STVDEMTKKFGTLTIHD93 39 3
hRio2-R 405GKIEELAQNFETMEFSR389 33 3
HPV E7 73HVDIRTLEDLLMGTLGIVC91 40 3
CDC7 456QDLRKLCERLRGMDSSTP473 36 3
Stradα 413GIFGLVTNLEELEVD427 32 3
SNUPN 1MEELSQALASSFSVSQDLNS20 33 3
PKI (I47A) 34NSNELALKLAGLDANK49 46 7
PKI (L42A/L45A) 34NSNELALKAAGADINK49 45 5

Quantitation of nuclear export activity

We developed a quantitation pipeline to measure the NES activity in live HeLa cells as illustrated in Figure 1A. The nuclear export activity of NESs was determined by measuring the steady-state distribution of fluorescence-tagged reporter proteins (EYFP2-SV40NLS-NES). HeLa cells were transiently transfected with different EYFP2-SV40NLS-NES constructs and live cell imaging was performed after 24 h. The ratio of cytoplasmic to nuclear YFP signal (RC/N) was normalized by the corresponding RC/N after 5 nM leptomycin B (LMB) treatment of 16–18 h in duplicate wells. RC/N with LMB treatment can account for the passive export of reporter proteins by diffusion, as LMB specifically inhibits CRM1 export activity.

Live cell imaging was performed at 37°C in a 5% CO2 atmosphere using a spinning disk confocal microscope system (Nikon-Andor) with a 40 × 0.6 NA air objective and the MetaMorph software. Z-stack images were obtained in the YFP and Hoechst channels using a step size of 0.6 μm (total z size 18 μm). In addition, a single differential interference contrast (DIC) image was taken in the middle of the z-stack. Cells were randomly selected for imaging if they 1) expressed YFP at adequate levels that the signal is not saturated, 2) contained no obvious abnormality observed under DIC, and 3) were not dividing, as evidenced by Hoechst staining.

The acquired z-stack images were imported into ImageJ (version: 1.49i) for further analysis. Four nuclear z-planes spanning the middle of the nucleus (total z size 1.8 μm) were selected and merged into a single YFP (by average intensity projection) and Hoechst image (by maximum intensity projection) for analysis. Watershed segmentation was applied to Hoechst images to define the nuclear region of interest (ROI). For each nuclear ROI, a cytoplasmic “ring” ROI with a thickness of 150 nm was generated by dilating the nuclear ROI twice and performing exclusive-or (XOR) operation on these two dilated areas in ImageJ. The mean intensities in nuclear and cytoplasmic ROIs were measured and exported to Microsoft Excel, where the ratio of cytoplasmic to nuclear YFP signal (RC/N) was calculated.

Cell culture

HeLa cells from the American Type Culture Collection were cultured in DMEM (Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS; Sigma-Aldrich) and 1% antibiotic-antimycotic (Life Technologies, Thermo Fisher Scientific) at 37°C in 5% CO2.

Transfections

HeLa cells that were seeded onto glass-bottom 24-well culture plates (Phenix Research Products) and grown to 50–70% confluency. Transfections were performed according to the manufacturer’s instructions with reduced DNA-to-reagent ratios of 1:1 (Lipofectamine 3000) or of 1:10 (Effectene), respectively. Cotransfection with red fluorescent protein (RFP)-NES was conducted using a transfection mixture of plasmid DNA at a reporter-to-inhibitor ratio of 1:9.

Quantitation of binding affinity for CRM1

The Kd values are obtained by competition differential bleaching experiments using a fluorescent probe FITC-PKINES that bleaches at distinct rates when unbound and bound to CRM1. FITC-PKINES undergo a reproducible differential bleaching when titrated with CRM1. The bleaching rate of the fluorescent probe is dependent on the concentration of the titrant CRM1, is saturable at high concentrations of CRM1, and can be fitted to a sigmoidal curve, which suggests a two-state behavior of the probe when it is unbound or bound to CRM1 (Fung et al., 2015). Differential bleaching of the probe can be counteracted by titration of MBP-NESs. MBP-NESs compete with FITC-PKINES for the NES-binding groove of CRM1 and the changes in bleaching rate of FITC-PKINES will reflect the fraction of CRM1 bound to the FITC-PKINES or to MBP-NES. Therefore, different MBP-NESs can be titrated to compete with FITC-PKINES for CRM1 to allow measurement of affinities of various MBP-NESs. Data were processed in PALMIST (Scheuermann et al., 2016) using averages of triplicate experiments without weighted fitting. Confidence levels at 95% were obtained by error-surface projection method. Nine binding affinity data were measured in this study while the others were measured in our previous works (Fung et al., 2015, 2017) and reanalyzed to obtain 95% confidence interval (see details in Supplemental Figure S3 and Table 1).

Statistical analysis

Mann–Whitney tests, p values (two-tailed), 95% confidence interval error bars, and Pearson correlation coefficients in this study were computed and calculated using the SciPy module of Python.

Supplementary Material

Acknowledgments

We thank members of the Live Cell Imaging Facility, Structural Biology Laboratory and Macromolecular Biophysics Resource, at the University of Texas Southwestern Medical Center for confocal microscope image, crystallographic, and biochemical data collection assistance and Lindsay Case for discussion. This work is funded by Cancer Prevention Research Institute of Texas (CPRIT) Grants RP150053, RP170170, and RP180410 (Y.M.C.), National Institutes of Health R01 GM069909 (Y.M.C.), Welch Foundation Grant I-1532 (Y.M.C.), and the University of Texas Southwestern Endowed Scholars Program (Y.M.C.).

Abbreviations used:

HIV

human immunodeficiency virus

LMB

leptomycin B

NES

nuclear export signal

NLS

nuclear localization signal

Footnotes

This article was published online ahead of print in MBoC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E18-02-0096) on June 21, 2018.

REFERENCES

  1. Cansizoglu AE, Lee BJ, Zhang ZC, Fontoura BMA, Chook YM. (2007). Structure-based design of a pathway-specific nuclear import inhibitor. Nat Struct Mol Biol , 452–454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Conti E, Uy M, Leighton L, Blobel G, Kuriyan J. (1998). Crystallographic analysis of the recognition of a nuclear localization signal by the nuclear import factor karyopherin α. Cell , 193–204. [DOI] [PubMed] [Google Scholar]
  3. Dong X, Biswas A, Chook YM. (2009). Structural basis for assembly and disassembly of the CRM1 nuclear export complex. Nat Struct Mol Biol , 558–560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Engelsma D, Valle N, Fish A, Salomé N, Almendral JM, Fornerod M. (2008). A supraphysiological nuclear export signal is required for parvovirus nuclear export. Mol Biol Cell , 2544–2552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fanara P, Hodel MR, Corbett AH, Hodel AE. (2000). Quantitative analysis of nuclear localization signal (NLS)-importin α interaction through fluorescence ddepolarization. J Biol Chem , 21218–21223. [DOI] [PubMed] [Google Scholar]
  6. Fornerod M, Ohno M, Yoshida M, Mattaj IW. (1997). CRM1 is an export receptor for leucine-rich nuclear export signals. Cell , 1051–1060. [DOI] [PubMed] [Google Scholar]
  7. Fu S-C, Huang H-C, Horton P, Juan H-F. (2012). ValidNESs: a database of validated leucine-rich nuclear export signals. Nucleic Acids Res , D338–D343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fukuda M, Asano S, Nakamura T, Adachi M, Yoshida M, Yanagida M, Nishida E. (1997). CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature , 308. [DOI] [PubMed] [Google Scholar]
  9. Fung HYJ, Fu S-C, Brautigam CA, Chook YM. (2015). Structural determinants of nuclear export signal orientation in binding to exportin CRM1. Elife , e10034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fung HYJ, Fu S-C, Chook YM. (2017). Nuclear export receptor CRM1 recognizes diverse conformations in nuclear export signals. Elife , e23961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Güttler T, Madl T, Neumann P, Deichsel D, Corsini L, Monecke T, Ficner R, Sattler M, Görlich D. (2010). NES consensus redefined by structures of PKI-type and Rev-type nuclear export signals bound to CRM1. Nat Struct Mol Biol , 1367–1376. [DOI] [PubMed] [Google Scholar]
  12. Hodel AE, Harreman MT, Pulliam KF, Harben ME, Holmes JS, Hodel MR, Berland KM, Corbett AH. (2006). Nuclear localization signal receptor affinity correlates with in vivo localization in Saccharomyces cerevisiae. J Biol Chem , 23545–23556. [DOI] [PubMed] [Google Scholar]
  13. Hodel MR, Corbett AH, Hodel AE. (2001). Dissection of a nuclear localization signal. J Biol Chem , 1317–1325. [DOI] [PubMed] [Google Scholar]
  14. Kırlı K, Karaca S, Dehne HJ, Samwer M, Pan KT, Lenz C, Urlaub H, Görlich D. (2015). A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. Elife , e11466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kobe B. (1999). Autoinhibition by an internal nuclear localization signal revealed by the crystal structure of mammalian importin α. Nat Struct Mol Biol , 388–397. [DOI] [PubMed] [Google Scholar]
  16. Kosugi S, Hasebe M, Entani T, Takayama S, Tomita M, Yanagawa H. (2008). Design of peptide inhibitors for the importin α/β nuclear import pathway by activity-based profiling. Chem Biol , 940–949. [DOI] [PubMed] [Google Scholar]
  17. Lott K, Bhardwaj A, Sims PJ, Cingolani G. (2011). A minimal nuclear localization signal (NLS) in human phospholipid scramblase 4 that binds only the minor NLS-binding site of importin α1. J Biol Chem , 28160–28169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Marfori M, Mynott A, Ellis JJ, Mehdi AM, Saunders NFW, Curmi PM, Forwood JK, Bodén M, Kobe B. (2011). Molecular basis for specificity of nuclear import and prediction of nuclear localization. Biochim Biophys Acta , 1562–1577. [DOI] [PubMed] [Google Scholar]
  19. Nakada R, Hirano H, Matsuura Y. (2015). Structure of importin-α bound to a non-classical nuclear localization signal of the influenza A virus nucleoprotein., Structure of importin-α bound to a non-classical nuclear localization signal of the influenza A virus nucleoprotein. Sci Rep , 15055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ossareh-Nazari B, Bachelerie F, Dargemont C. (1997). Evidence for a role of CRM1 in signal-mediated nuclear protein export. Science , 141–144. [DOI] [PubMed] [Google Scholar]
  21. Scheuermann TH, Padrick SB, Gardner KH, Brautigam CA. (2016). On the acquisition and analysis of microscale thermophoresis data. Anal Biochem , 79–93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Stade K, Ford CS, Guthrie C, Weis K. (1997). Exportin 1 (Crm1p) is an essential nuclear export factor. Cell , 1041–1050. [DOI] [PubMed] [Google Scholar]
  23. Thakar K, Karaca S, Port SA, Urlaub H, Kehlenbach RH. (2013). Identification of CRM1-dependent nuclear export cargos using quantitative mass spectrometry. Mol Cell Proteomics , 664–678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wen W, Meinkoth JL, Tsien RY, Taylor SS. (1995). Identification of a signal for rapid export of proteins from the nucleus. Cell , 463–473. [DOI] [PubMed] [Google Scholar]
  25. Wu W, Sankhala RS, Florio TJ, Zhou L, Nguyen NLT, Lokareddy RK, Cingolani G, Panté N. (2017). Synergy of two low-affinity NLSs determines the high avidity of influenza A virus nucleoprotein NP for human importin α isoforms. Sci Rep , 11381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Xu D, Grishin NV, Chook YM. (2012). NESdb: a database of NES-containing CRM1 cargoes. Mol Biol Cell , 3673–3676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Xu D, Marquis K, Pei J, Fu S-C, Cağatay T, Grishin NV, Chook YM. (2015). LocNES: a computational tool for locating classical NESs in CRM1 cargo proteins. Bioinformatics , 1357–1365. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials


Articles from Molecular Biology of the Cell are provided here courtesy of American Society for Cell Biology

RESOURCES